HCM
BDSI

Highbridge Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Highbridge Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11,300
Closed -$136K – 1794
2014
Q4 		$136K Sell
11,300
-11,800
-51% -$179K ﹤0.01% 1092
2014
Q3 		$394K Buy
+23,100
New +$335K 0.01% 918

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 42.58% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
B
Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

Highbridge Capital Management's BDSI Position: Q4 2016 in Review

Highbridge Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2016, closing a stake of 13,611 shares — an estimated $37K sold.

Highbridge Capital Management first reported a position in BDSI in Q4 2013 and held it in 4 quarters. The position peaked at $603K in Q4 2015. 77 funds tracked by Wall St. Rank hold BDSI as of Q4 2016.

  • Highbridge Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 13,611 BioDelivery Sciences International, Inc. shares in Q4 2016, an estimated $37K.
  • Highbridge Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2013 and held it in 4 quarters.
  • Highbridge Capital Management's BioDelivery Sciences International, Inc. position peaked at $603K in Q4 2015.
  • 77 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2016.

Based on Highbridge Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.